Reaction
Post Transplant Distal Limb Syndrome reporting signals
As of the last recalculation, Post Transplant Distal Limb Syndrome appears in 203 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is TACROLIMUS (PRR 611.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tacrolimus | 167 | 611.8 | 612.5 |
| Tacrolimus Ointment 0.1% | 152 | 495.2 | 495.8 |
| Tacrolimus Extended-Release Capsules | 152 | 493.8 | 494.4 |
| Basiliximab | 13 | 121.0 | 121.2 |
| Anti-Thymocyte Globulin (Rabbit) | 9 | 119.7 | 119.8 |
| Abacavir Sulfate | 9 | 99.1 | 99.2 |
| Busulfan | 13 | 90.4 | 90.5 |
| Everolimus Tablets | 13 | 84.9 | 84.9 |
| Ritonavir 100 Mg | 9 | 64.6 | 64.6 |
| Darunavir | 9 | 63.8 | 63.8 |